Perspectives of HPV vaccination among young adults: a qualitative systematic review and evidence synthesis protocol

Author:

Mantina Namoonga MORCID,Nakayima Miiro Flavia,Smith Jonathan,McClelland Deborah Jean,Magrath Priscilla Anne,Madhivanan Purnima

Abstract

IntroductionHuman papillomavirus (HPV) is the causative agent of nearly all cervical cancers. Despite the proven safety and efficacy of HPV vaccines in preventing HPV-related cancers, the global vaccine coverage rate is estimated to only be 15%. HPV vaccine coverage rates are more actively tracked and reported for adolescents 17 years and younger but there is still a critical window of opportunity to intervene and promote HPV vaccination among young adults aged 18–26 years who are still eligible to be vaccinated. This protocol for a qualitative evidence synthesis aims to review perspectives of HPV vaccination among young adults (18–26 years) and identify facilitators and barriers that influence HPV vaccination uptake and decision-making.Methods and analysisSeven databases will be searched from 1 January 2006 to the date of final search. For inclusion, studies must report HPV vaccination perspectives of young adults aged 18–26 years and use qualitative study methods or analysis techniques. Studies will be screened in a two-stage process guided by the eligibility criteria. Final included studies will be evaluated for methodological strengths and limitations using the Critical Appraisal Skills Programme quality assessment tool for qualitative studies. After data extraction, framework analysis will be used to analyse the data applying the socioecological model. Finally, the Grading of Recommendations Assessment, Development and Evaluation - Confidence in the Evidence from Reviews of Qualitative research will be applied to evaluate the confidence in synthesised qualitative findings. The methodology of this review follows the Cochrane Handbook guidelines on qualitative evidence syntheses.Ethics and disseminationFormal ethical approval is not required for this study. Findings will be disseminated through peer-reviewed publications, conference presentations and professional networks.PROSPERO registration numberCRD42023417052.

Publisher

BMJ

Subject

General Medicine

Reference35 articles.

1. Worldwide burden of cancer attributable to HPV by site, country and HPV type;de Martel;Intl Journal of Cancer,2017

2. Cervical cancer, Available: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer [Accessed 1 Apr 2023].

3. HPV Vaccine Administration, Available: https://www.cdc.gov/vaccines/vpd/hpv/hcp/administration.html [Accessed 1 Apr 2023].

4. World Health Organization . WHO updates recommendations on HPV vaccination schedule, Available: https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule [Accessed 1 Apr 2023].

5. Centers for Disease Control and Prevention . HPV Vaccine Safety and Effectiveness Data, Available: https://www.cdc.gov/hpv/hcp/vaccine-safety-data.html [Accessed 1 Apr 2023].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3